[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356772-105":59,"doc-detail-356772-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tumor-cell-specific-loss-of-gpx4-reprograms-triacylglycerol-metabolism-to-escape-ferroptosis-and-impair-antitumor-immunity-in-non-small-cell-lung-cancer-abstract","Tumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in non-small cell lung cancer - Abstract","","Glutathione peroxidase 4 (GPX4) functions as a master regulator of ferroptosis and a potential cancer target. Tumor-cell inducible GPX4 knockout unexpectedly accelerates non-small cell lung cancer progression in KrasLSL-G12D/+Lkb1fl/fl and KrasLSL-G12D/+Tp53fl/fl mice, while GPX4 overexpression reverses this effect. GPX4-deficient cells evade ferroptosis by increasing DGAT1/2, boosting triacylglycerol and oxidized TAG synthesis, and forming lipid droplets, then releasing TAG/oxTAG to disrupt CD8+ T-cell function and reshape the immunoinhibitory tumor microenvironment. DGAT1/2 inhibition or tumor-cell GPX4 overexpression restores ferroptotic sensitivity and activates T cells to suppress tumor growth.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-cell-specific-loss-of-gpx4-reprograms-triacylglycerol-metabolism-to-escape-ferroptosis-and-impair-antitumor-immunity-in-non-small-cell-lung-cancer-abstract/356772/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-cell-specific-loss-of-gpx4-reprograms-triacylglycerol-metabolism-to-escape-ferroptosis-and-impair-antitumor-immunity-in-non-small-cell-lung-cancer-abstract/356772.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does tumor-cell GPX4 loss affect ferroptosis and tumor progression in NSCLC?","Question",{"text":113,"@type":114},"Inducible GPX4 knockout in tumor cells promotes NSCLC progression and enables ferroptosis escape, whereas inducible tumor-cell GPX4 overexpression has the opposite effect in mouse models.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What mechanism allows GPX4-deficient tumor cells to escape ferroptosis?",{"text":118,"@type":114},"They upregulate DGAT1/2 to enhance triacylglycerol (TAG) and oxidized TAG (oxTAG) synthesis and increase lipid droplet formation, reducing ferroptosis vulnerability.",{"name":120,"@type":111,"acceptedAnswer":121},"How does GPX4 deficiency influence antitumor immunity in the tumor microenvironment?",{"text":122,"@type":114},"GPX4-deficient cells secrete TAG and oxTAG extracellularly, impairing antitumor CD8+ T-cell function and coordinating an immunoinhibitory tumor microenvironment.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356772,1790192565,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Protein & Cell, 2026, 17 , 421–437 [https://doi.org/10.1093/procel/pwaf101](https://doi.org/10.1093/procel/pwaf101)  \nAdvance access publication 19 November 2025  \n& Research Article  \nProtein Cell  \nResearch Article  \nTumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in non-small cell lung cancer  \nPeng Wang1,2,‡,, Shengdan Zhang3,‡, Xin Chen4,‡, Xu-Dong Yang1, Shi Huang1, Huiyong Yin4,, Hao-Yu Duan1, Fuling Zhou2,*,, Jia Yu5,*, Bo Zhong1,6,*,, Dandan Lin1,*,  \n1Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Cancer Center, Renmin Hospital of Wuhan University, Medical Research Institute, Frontier Science Center of Immunology and Metabolism, College of Life Sciences, State Key Laboratory of Metabolism and Regulation in Complex Organisms, State Key Laboratory of Virology and Biosafety, Hubei Provincial Research Center for Basic Biological Sciences, Wuhan University, Wuhan 430071, China  \n2Research Center for Lifespan Health, School of Nursing, Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China  \n3Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China  \n4AS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China  \n5Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, China 6TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430071, China  \n‡= equal contribution.  \n*Correspondence: [zhoufuling@whu.edu.cn](zhoufuling@whu.edu.cn) (F. Zhou), [yogaqq116@whu.edu.cn](yogaqq116@whu.edu.cn) (J. Yu), [zhongbo@whu.edu.cn](zhongbo@whu.edu.cn) (B. Zhong), [lindandan@whu.edu.cn](lindandan@whu.edu.cn)  \n(D. Lin)  \nAbstract  \nGlutathione peroxidase 4 (GPX4) is a master regulator of ferroptosis, a process that has been proposed as a potential therapeutic strategy for cancer. Here, we have unexpectedly found that inducible knockout of GPX4 in tumor cells significantly promotes non-small cell lung cancer (NSCLC) progression in the autochthonous KrasLSL-G12D/+Lkb1fl/fl (KL) and KrasLSL-G12D/+Tp53fl/fl (KP) mouse models, whereas inducible overexpression of GPX4 in tumor cells exerts the opposite effect. GPX4-deficient tumor cells evade ferroptosis by upregulating the expression of DGAT1/2 to promote the synthesis of triacylglycerol (TAG) and oxidized TAG (oxTAG) and the formation of lipid droplets in cells. In addition, GPX4-deficient tumor cells secrete TAG and oxTAG into the extracellular space to induce dysfunction of antitumor CD8+ T cells, thereby coordinating an immunoinhibitory tumor microenvironment (TME) . Consistently, treatment with DGAT1/2 inhibitors or inducible overexpression of GPX4 in tumor cells significantly resensitizes tumor cells to ferroptosis and ignites the activation ofT cells in the TME to inhibit NSCLC progression. These findings highlight a previously uncharacterized role of tumor cell-specific GPX4 in NSCLC progression and provide potential therapeutic strategies for NSCLC.  \nKeywords GPX4, triacylglycerol, lipid droplets, lipid release, non-small cell lung cancer, tumor microenvironment  \nIntroduction  \nGlutathione peroxidase 4 (GPX4) is an enzyme that catalyzes the reduction of cytotoxic phospholipid hydroperoxides (PL-OOH) into PL alcohols (PL-OH) and thereby protects against ferroptosis (Cozza et al. , 2017; Ursini et al. , 1982) .  \nDeletion of GPX4 leads to the accumulation of PL peroxidesand induces cell death in in vitro cultured cells (Canli et al. , 2016; Hambright et al. , 2017 ; Matsushita et al. , 2015 ; Muri et al. , 2019; Seiler et al. , 2008 ; Xu et al. , 2021a; Yao et al. , 2021) . Accordingly, Gpx4−/− mouse embryos die at E7 .5 and  \nReceived 26 May 2025; accepted 12 November 2025  \n© The Author(s) 2025. Published by Oxford Unive","cbCaiu0egvS7ol3b","https://ap.wps.com/l/cbCaiu0egvS7ol3b","pdf",10710464,17,"English","# Abstract\n# Introduction","[{\"question\":\"How does tumor-cell GPX4 loss affect ferroptosis and tumor progression in NSCLC?\",\"answer\":\"Inducible GPX4 knockout in tumor cells promotes NSCLC progression and enables ferroptosis escape, whereas inducible tumor-cell GPX4 overexpression has the opposite effect in mouse models.\"},{\"question\":\"What mechanism allows GPX4-deficient tumor cells to escape ferroptosis?\",\"answer\":\"They upregulate DGAT1/2 to enhance triacylglycerol (TAG) and oxidized TAG (oxTAG) synthesis and increase lipid droplet formation, reducing ferroptosis vulnerability.\"},{\"question\":\"How does GPX4 deficiency influence antitumor immunity in the tumor microenvironment?\",\"answer\":\"GPX4-deficient cells secrete TAG and oxTAG extracellularly, impairing antitumor CD8+ T-cell function and coordinating an immunoinhibitory tumor microenvironment.\"}]","Tumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in non-small cell lung cancer - Abstract | PDF",1790127222,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4e4199416f954d548bfdd82507efde2.webp",983,1292,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e62760c890cee0c6eedd757266f117fb.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0277401f8837dd9ec2eedb97d51c8486.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a7b95f40b0467f84a6cd546574111c6.webp",980,1288]